• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT的最大标准摄取值、代谢肿瘤体积和总病变糖酵解对肾癌患者的预后价值:一项系统评价和荟萃分析方案

Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis.

作者信息

Xuan Dongchun, Wen Weibo, Tian Shengri, Piao Minhu, Xu Dongyuan, Liu Lan

机构信息

Center of Morphological Experiment, Medical College of Yanbian University.

Department of Nuclear Medicine.

出版信息

Medicine (Baltimore). 2020 May;99(20):e19988. doi: 10.1097/MD.0000000000019988.

DOI:10.1097/MD.0000000000019988
PMID:32443301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7254885/
Abstract

PURPOSE

We present a comprehensive systematic review of the documented literature on parameters derived from F-fluorodeoxyglucose positron emission tomography (F-FDG PET) and meta-analysis of the prognostic value of maximal standard uptake value (SUVmax), metabolic tumor volume (MTV) and total lesional glycolysis (TLG) in patients with renal carcinoma (RCC).

PATIENTS AND METHODS

Relevant articles in English from PubMed, EMBASE, and the Cochrane Library were retrieved. Pooled hazard ratio (HR) values were used to assess the prognostic value of SUVmax, MTV, and TLG.

RESULTS

A total of 10 primary studies involving 780 patients with RCC were included. The combined HRs for event-free survival were 1.32 (95% CI 1.10-1.58) for SUVmax, 2.40 (95% CI 1.20-4.79) for MTV, and 3.31 (95% CI 1.68-6.50) for TLG. Pooled HRs for overall survival were 1.264 (95% CI 1.124-1.421) for SUVmax, 3.52 (95% CI 1.451-8.536) for MTV, and 6.33 (95% CI 1.32-30.30) for TLG. Subgroup analysis revealed SUVmax as an independent risk factor for patients with recurrence or metastasis.

CONCLUSION

The present meta-analysis confirmed that despite the clinical heterogeneity of RCC and adoption of various methods between studies, high SUVmax is a significant prognostic factor, especially in patients with recurrence or metastasis. MTV and TLG were associated with prediction of higher risk of adverse events or death in patients with RCC.

摘要

目的

我们对源自氟脱氧葡萄糖正电子发射断层扫描(F-FDG PET)的参数的文献进行了全面的系统评价,并对最大标准摄取值(SUVmax)、代谢肿瘤体积(MTV)和总病变糖酵解(TLG)在肾癌(RCC)患者中的预后价值进行了荟萃分析。

患者与方法

检索了PubMed、EMBASE和Cochrane图书馆中用英文发表的相关文章。采用合并风险比(HR)值评估SUVmax、MTV和TLG的预后价值。

结果

共纳入10项涉及780例RCC患者的初步研究。SUVmax的无事件生存合并HR为1.32(95%CI 1.10-1.58),MTV为2.40(95%CI 1.20-4.79),TLG为3.31(95%CI 1.68-6.50)。SUVmax的总生存合并HR为1.264(95%CI 1.124-1.421),MTV为3.52(95%CI 1.451-8.536),TLG为6.33(95%CI 1.32-30.30)。亚组分析显示SUVmax是复发或转移患者的独立危险因素。

结论

本荟萃分析证实,尽管RCC存在临床异质性且各研究采用的方法不同,但高SUVmax是一个重要的预后因素,尤其是在复发或转移患者中。MTV和TLG与RCC患者不良事件或死亡风险较高的预测相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/b34076fa24a9/medi-99-e19988-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/2d7800ba856c/medi-99-e19988-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/cf0ead133aa5/medi-99-e19988-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/68e3ca2d463b/medi-99-e19988-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/b34076fa24a9/medi-99-e19988-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/2d7800ba856c/medi-99-e19988-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/cf0ead133aa5/medi-99-e19988-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/68e3ca2d463b/medi-99-e19988-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0e/7254885/b34076fa24a9/medi-99-e19988-g007.jpg

相似文献

1
Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with renal carcinoma: A protocol for systematic review and meta analysis.18F-FDG PET/CT的最大标准摄取值、代谢肿瘤体积和总病变糖酵解对肾癌患者的预后价值:一项系统评价和荟萃分析方案
Medicine (Baltimore). 2020 May;99(20):e19988. doi: 10.1097/MD.0000000000019988.
2
Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.预处理代谢肿瘤体积和 18F-FDG PET/CT 总病变糖酵解对接受抗血管内皮生长因子靶向药物治疗的转移性肾细胞癌患者的预后价值。
Clin Nucl Med. 2017 May;42(5):e235-e241. doi: 10.1097/RLU.0000000000001612.
3
Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with breast cancer: A systematic review and meta-analysis.正电子发射断层扫描/计算机断层扫描最大标准摄取值、代谢肿瘤体积和总病灶糖酵解在乳腺癌患者中的预后价值:系统评价和荟萃分析。
PLoS One. 2019 Dec 11;14(12):e0225959. doi: 10.1371/journal.pone.0225959. eCollection 2019.
4
Prognostic value of 18F-FDG-PET/CT in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.18F-FDG-PET/CT在鼻咽癌患者中的预后价值:一项系统评价和荟萃分析
Oncotarget. 2017 May 16;8(20):33884-33896. doi: 10.18632/oncotarget.13934.
5
Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.正电子发射断层扫描/计算机断层扫描的最大标准摄取值、代谢肿瘤体积和总病变糖酵解在鼻咽癌患者中的预后价值:一项系统评价和荟萃分析。
Medicine (Baltimore). 2017 Sep;96(37):e8084. doi: 10.1097/MD.0000000000008084.
6
Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.18F-FDG-PET/CT参数对胰腺癌患者的预后价值:一项系统评价和荟萃分析
Medicine (Baltimore). 2017 Aug;96(33):e7813. doi: 10.1097/MD.0000000000007813.
7
Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.治疗前18F-FDG PET-CT对鼻咽癌患者的预后价值
Medicine (Baltimore). 2017 Apr;96(17):e6721. doi: 10.1097/MD.0000000000006721.
8
The correlation of F-FDG PET/CT metabolic parameters, clinicopathological factors, and prognosis in breast cancer.乳腺癌中 F-FDG PET/CT 代谢参数与临床病理因素及预后的相关性。
Clin Transl Oncol. 2021 Mar;23(3):620-627. doi: 10.1007/s12094-020-02457-w. Epub 2020 Jul 18.
9
Prognostic prediction by F-FDG-PET/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis.神经母细胞瘤患者中F-FDG-PET/CT参数的预后预测:一项系统评价和荟萃分析
Front Oncol. 2023 Jul 14;13:1208531. doi: 10.3389/fonc.2023.1208531. eCollection 2023.
10
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Renal Cell Carcinoma.代谢肿瘤体积和总病变糖酵解对术前 18F-FDG PET/CT 肾细胞癌患者的预后价值。
Clin Nucl Med. 2017 Apr;42(4):e177-e182. doi: 10.1097/RLU.0000000000001552.

引用本文的文献

1
The Utility of F-FDG PET/CT in Detecting Multiple Metastases in Papillary Renal Cell Carcinoma.F-FDG PET/CT在检测乳头状肾细胞癌多发转移中的应用价值
Mol Imaging Radionucl Ther. 2025 Feb 7;34(1):64-65. doi: 10.4274/mirt.galenos.2024.02259.
2
The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis.最大摄取值和表观扩散系数在鉴别卵巢或附件良恶性肿块中的诊断性能:一项荟萃分析
Front Oncol. 2022 Feb 9;12:840433. doi: 10.3389/fonc.2022.840433. eCollection 2022.
3
Prognostic Value of Volume-Based Parameters Measured by SSTR PET/CT in Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.正电子发射断层扫描成像在代谢活跃型肾细胞癌中的作用。
Curr Urol Rep. 2019 Aug 29;20(10):56. doi: 10.1007/s11934-019-0932-2.
2
FDG PET/CT as a survival prognostic factor in patients with advanced renal cell carcinoma.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为晚期肾细胞癌患者生存预后因素。
Clin Exp Med. 2019 Feb;19(1):143-148. doi: 10.1007/s10238-018-0539-9. Epub 2018 Nov 28.
3
FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.
生长抑素受体PET/CT测量的基于体积参数在神经内分泌肿瘤中的预后价值:一项系统评价和荟萃分析
Front Med (Lausanne). 2021 Nov 26;8:771912. doi: 10.3389/fmed.2021.771912. eCollection 2021.
首次分子靶向治疗后 FDG PET/CT 预测肾细胞癌患者的生存情况。
Cancer Chemother Pharmacol. 2018 Apr;81(4):739-744. doi: 10.1007/s00280-018-3542-7. Epub 2018 Feb 20.
4
Recent developments in small molecule therapies for renal cell carcinoma.肾细胞癌小分子疗法的最新进展。
Eur J Med Chem. 2017 Dec 15;142:383-392. doi: 10.1016/j.ejmech.2017.08.007. Epub 2017 Aug 9.
5
Current management of metastatic renal cell carcinoma: evolving new therapies.转移性肾细胞癌的当前管理:不断发展的新疗法。
Curr Opin Support Palliat Care. 2017 Sep;11(3):231-237. doi: 10.1097/SPC.0000000000000277.
6
Prognostic Value of Percentage Change in Metabolic Parameters as Measured by Dual-Time Point F-FDG PET/CT in Premenopausal Women with Invasive Ductal Breast Carcinoma.双时间点F-FDG PET/CT测量的代谢参数变化百分比在绝经前浸润性导管癌女性中的预后价值
J Womens Health (Larchmt). 2017 Oct;26(10):1131-1137. doi: 10.1089/jwh.2016.6256. Epub 2017 May 12.
7
One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.使用氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)对依维莫司治疗的肾细胞癌进行的1个月评估可预测无进展生存期和总生存期。
Cancer Chemother Pharmacol. 2017 May;79(5):855-861. doi: 10.1007/s00280-017-3275-z. Epub 2017 Mar 22.
8
Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.预处理代谢肿瘤体积和 18F-FDG PET/CT 总病变糖酵解对接受抗血管内皮生长因子靶向药物治疗的转移性肾细胞癌患者的预后价值。
Clin Nucl Med. 2017 May;42(5):e235-e241. doi: 10.1097/RLU.0000000000001612.
9
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Renal Cell Carcinoma.代谢肿瘤体积和总病变糖酵解对术前 18F-FDG PET/CT 肾细胞癌患者的预后价值。
Clin Nucl Med. 2017 Apr;42(4):e177-e182. doi: 10.1097/RLU.0000000000001552.
10
Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.体重指数与肿瘤18F-FDG摄取情况相结合可改善乳腺癌患者的风险分层。
PLoS One. 2016 Oct 31;11(10):e0165814. doi: 10.1371/journal.pone.0165814. eCollection 2016.